NIAID Investigator-Initiated P01
Supports investigator-led infectious disease and immunology multi-project teams under NIAID.
PAR-27-082 is NIAID's standing Program Announcement with Special Receipt for investigator-initiated Program Project (P01) applications addressing the full scope of the National Institute of Allergy and Infectious Diseases mission. The announcement was posted May 7, 2026, last updated May 13, 2026, and remains open through May 25, 2029, with an archive date of July 24, 2029. Contact for applicants …
Biology and pathogenesis of infectious microbes (including HIV); host-microbe interactions; immune system regulation; immune dysfunction (allergy, asthma, autoimmunity, immunodeficiency, transplant rejection); translational research for vaccines, therapeutics, and diagnostics.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from NIAID
All grants from this funder →Coccidioidomycosis Collaborative Research Centers — RFA-AI-27-012
🇺🇸NIAID · United States
Supports translational vaccine teams targeting valley fever through collaborative centers.
Impact of Initial Influenza Exposure on Immunity in Infants — RFA-AI-27-019
NIAID · United States
Supports longitudinal infant influenza immunity studies to guide next-generation vaccine design.
Tuberculosis Research Advancement Centers (TRACs) — RFA-AI-27-016
🇺🇸NIAID · United States
Supports tuberculosis research centers through shared resources and interdisciplinary teams.
Similar grants
Browse the directory →
CFF Mission Ventures Industry Investment
🇺🇸CFF · United States
Offers startup and industry teams with commercialization support for CFF Mission Ventures Industry Investment in biotechnology, medical technology, and synthetic biology.
NIH SBIR Phase I
🇺🇸NIH SEED · United States
Funds early stage United States biomedical teams through NIH seed support for feasibility work on prototype ready ideas.
NIH SBIR Phase II
🇺🇸NIH SEED · United States
Supports United States biomedical small businesses advancing successful feasibility work into scale-up development.
NIAMS SBIR — Small Business Innovation Research
🇺🇸NIAMS · United States
Supports small businesses and researchers advancing arthritis, skin, and musculoskeletal innovation through staged aid.
NICHD R01 Research Project Grant
🇺🇸NICHD · United States
Supports investigator-led biomedical studies across the NICHD portfolio in the United States.
NSF SBIR Phase I
🇺🇸NSF · United States
Funds United States deep-tech startups demonstrating scientific feasibility of novel science and engineering innovations.